Publication | Open Access
Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution
84
Citations
27
References
2011
Year
PORT can significantly improve the survival of patients with resected pathological stage IIIA-N2 NSCLC. A prospective randomized multicenter clinical trial is ongoing.
| Year | Citations | |
|---|---|---|
Page 1
Page 1